1. A nervous tumor microenvironment: the impact of adrenergic stress on cancer cells, immunosuppression, and immunotherapeutic response

   • Jason W.-L. Eng
   • Kathleen M. Kokolus
   • Elizabeth A. Repasky

   Review 12 October 2014 Pages: 1115 - 1128

   

2. Mannose-Binding Lectin (MBL) and MBL-associated serine protease-2 (MASP-2) in women with malignant and benign ovarian tumours

   • Anna St. Swierzko
   • Agnieszka Szala
   • Maciej Cedzynski

   Original Article Open access 20 July 2014 Pages: 1129 - 1140

   

3. AE37 peptide vaccination in prostate cancer: identification of biomarkers in the context of prognosis and prediction

   • Sonia A. Perez
   • Eleftheria A. Anastasopoulou
   • Constantin N. Baxevanis

   Original Article 23 July 2014 Pages: 1141 - 1150

   

4. Functional autoantibodies against SSX-2 and NY-ESO-1 in multiple myeloma patients after allogeneic stem cell transplantation

   • Tim Luetkens
   • Sebastian Kobold
   • Djordje Atanackovic

   Original Article 31 July 2014 Pages: 1151 - 1162

   

5. A novel T cell receptor single-chain signaling complex mediates antigen-specific T cell activity and tumor control

   • Jennifer D. Stone
   • Daniel T. Harris
   • David M. Kranz

   Original Article 01 August 2014 Pages: 1163 - 1176

   

6. Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer

   • Manja Idorn
   • Tania Køllgaard
   • Per thor Straten

   Original Article 02 August 2014 Pages: 1177 - 1187

   

7. FOXP3 and CTLA4 overexpression in multiple myeloma bone marrow as a sign of accumulation of CD4⁺ T regulatory cells

   • Walter Moises Tobias Braga
   • Bruna Raphaeli da Silva
   • Gisele Wally Braga Colleoni

   Original Article Open access 07 August 2014 Pages: 1189 - 1197

   

8. Harmonisation of short-term in vitro culture for the expansion of antigen-specific CD8⁺ T cells with detection by ELISPOT and HLA-multimer staining

   • Lindsey Chudley
   • Katy J. McCann
   • Christian H. Ottensmeier

   Original Article Open access 19 August 2014 Pages: 1199 - 1211

   

9. CpG-mediated modulation of MDSC contributes to the efficacy of Ad5-TRAIL therapy against renal cell carcinoma

   • Britnie R. James
   • Kristin G. Anderson
   • Thomas S. Griffith

   Original Article 21 August 2014 Pages: 1213 - 1227

   

10. Fast-growing in-transit melanoma metastasis after intratumoral interleukin-2

    • David Moreno-Ramírez
    • Martina Alés-Martínez
    • Lara Ferrándiz

    Letter to the Editors 24 July 2014 Pages: 1229 - 1230

    

11. Limited efficacy of intratumoral IL-2 applied to large melanoma metastases

    • Benjamin Weide
    • Thomas Kurt Eigentler
    • Claus Garbe

    Letter to the Editors 24 July 2014 Pages: 1231 - 1232

12. Erratum to: Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma

    • Ester Simeone
    • Giusy Gentilcore
    • Paolo A. Ascierto

    Erratum 25 September 2014 Pages: 1233 - 1233